テノホビルアラフェナミドフマル酸塩のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Tenofovir Alafenamide Fumarate Market Insights, Forecast to 2028

• レポートコード：QY2203B04287
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のテノホビルアラフェナミドフマル酸塩の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にテノホビルアラフェナミドフマル酸塩の世界市場のxxx％を占める「純度97％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「医療」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のテノホビルアラフェナミドフマル酸塩の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのテノホビルアラフェナミドフマル酸塩市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのテノホビルアラフェナミドフマル酸塩市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

テノホビルアラフェナミドフマル酸塩のグローバル主要メーカーには、AFINE CHEMICALS LIMITED、BOC Sciences、ENBRIDGE PHARMTECH、SimSon Pharma Limited、Valorpharm、Watsonなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

テノホビルアラフェナミドフマル酸塩市場は、種類と用途によって区分されます。世界のテノホビルアラフェナミドフマル酸塩市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度97％、純度98％、純度99％。

【用途別セグメント】
医療、化学工業、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- テノホビルアラフェナミドフマル酸塩製品概要
- 種類別市場（純度97％、純度98％、純度99％。）
- 用途別市場（医療、化学工業、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のテノホビルアラフェナミドフマル酸塩販売量予測2017-2028
- 世界のテノホビルアラフェナミドフマル酸塩売上予測2017-2028
- テノホビルアラフェナミドフマル酸塩の地域別販売量
- テノホビルアラフェナミドフマル酸塩の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別テノホビルアラフェナミドフマル酸塩販売量
- 主要メーカー別テノホビルアラフェナミドフマル酸塩売上
- 主要メーカー別テノホビルアラフェナミドフマル酸塩価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度97％、純度98％、純度99％。）
- テノホビルアラフェナミドフマル酸塩の種類別販売量
- テノホビルアラフェナミドフマル酸塩の種類別売上
- テノホビルアラフェナミドフマル酸塩の種類別価格
・用途別市場規模（医療、化学工業、その他）
- テノホビルアラフェナミドフマル酸塩の用途別販売量
- テノホビルアラフェナミドフマル酸塩の用途別売上
- テノホビルアラフェナミドフマル酸塩の用途別価格
・北米市場
- 北米のテノホビルアラフェナミドフマル酸塩市場規模（種類別、用途別）
- 主要国別のテノホビルアラフェナミドフマル酸塩市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのテノホビルアラフェナミドフマル酸塩市場規模（種類別、用途別）
- 主要国別のテノホビルアラフェナミドフマル酸塩市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のテノホビルアラフェナミドフマル酸塩市場規模（種類別、用途別）
- 主要国別のテノホビルアラフェナミドフマル酸塩市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のテノホビルアラフェナミドフマル酸塩市場規模（種類別、用途別）
- 主要国別のテノホビルアラフェナミドフマル酸塩市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのテノホビルアラフェナミドフマル酸塩市場規模（種類別、用途別）
- 主要国別のテノホビルアラフェナミドフマル酸塩市場規模（トルコ、サウジアラビア）
・企業情報
AFINE CHEMICALS LIMITED、BOC Sciences、ENBRIDGE PHARMTECH、SimSon Pharma Limited、Valorpharm、Watson
・産業チェーン及び販売チャネル分析
- テノホビルアラフェナミドフマル酸塩の産業チェーン分析
- テノホビルアラフェナミドフマル酸塩の原材料
- テノホビルアラフェナミドフマル酸塩の生産プロセス
- テノホビルアラフェナミドフマル酸塩の販売及びマーケティング
- テノホビルアラフェナミドフマル酸塩の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- テノホビルアラフェナミドフマル酸塩の産業動向
- テノホビルアラフェナミドフマル酸塩のマーケットドライバー
- テノホビルアラフェナミドフマル酸塩の課題
- テノホビルアラフェナミドフマル酸塩の阻害要因
・主な調査結果

Tenofovir alafenamide hemifumarate, also known as Tenofovir alafenamide fumarate (2:1), is a nucleotide reverse transcriptase inhibitor (NRTIs) and a novel prodrug of tenofovir. By blocking reverse transcriptase, TAF prevents HIV from multiplying and can reduce the amount of HIV in the body.
Market Analysis and Insights: Global Tenofovir Alafenamide Fumarate Market
Due to the COVID-19 pandemic, the global Tenofovir Alafenamide Fumarate market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Purity 97% accounting for % of the Tenofovir Alafenamide Fumarate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Medicine segment is altered to an % CAGR throughout this forecast period.
China Tenofovir Alafenamide Fumarate market size is valued at US$ million in 2021, while the US and Europe Tenofovir Alafenamide Fumarate are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Tenofovir Alafenamide Fumarate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Tenofovir Alafenamide Fumarate include AFINE CHEMICALS LIMITED, BOC Sciences, ENBRIDGE PHARMTECH, SimSon Pharma Limited, Valorpharm and Watson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Tenofovir Alafenamide Fumarate capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Tenofovir Alafenamide Fumarate by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Tenofovir Alafenamide Fumarate Scope and Segment
Tenofovir Alafenamide Fumarate market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Tenofovir Alafenamide Fumarate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity 97%
Purity 98%
Purity 99%
Segment by Application
Medicine
Chemical Industry
Other
By Company
AFINE CHEMICALS LIMITED
BOC Sciences
ENBRIDGE PHARMTECH
SimSon Pharma Limited
Valorpharm
Watson
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Tenofovir Alafenamide Fumarate Product Introduction
1.2 Market by Type
1.2.1 Global Tenofovir Alafenamide Fumarate Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity 97%
1.2.3 Purity 98%
1.2.4 Purity 99%
1.3 Market by Application
1.3.1 Global Tenofovir Alafenamide Fumarate Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Medicine
1.3.3 Chemical Industry
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Tenofovir Alafenamide Fumarate Production
2.1 Global Tenofovir Alafenamide Fumarate Production Capacity (2017-2028)
2.2 Global Tenofovir Alafenamide Fumarate Production by Region: 2017 VS 2021 VS 2028
2.3 Global Tenofovir Alafenamide Fumarate Production by Region
2.3.1 Global Tenofovir Alafenamide Fumarate Historic Production by Region (2017-2022)
2.3.2 Global Tenofovir Alafenamide Fumarate Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Tenofovir Alafenamide Fumarate Sales in Volume & Value Estimates and Forecasts
3.1 Global Tenofovir Alafenamide Fumarate Sales Estimates and Forecasts 2017-2028
3.2 Global Tenofovir Alafenamide Fumarate Revenue Estimates and Forecasts 2017-2028
3.3 Global Tenofovir Alafenamide Fumarate Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Tenofovir Alafenamide Fumarate Sales by Region
3.4.1 Global Tenofovir Alafenamide Fumarate Sales by Region (2017-2022)
3.4.2 Global Sales Tenofovir Alafenamide Fumarate by Region (2023-2028)
3.5 Global Tenofovir Alafenamide Fumarate Revenue by Region
3.5.1 Global Tenofovir Alafenamide Fumarate Revenue by Region (2017-2022)
3.5.2 Global Tenofovir Alafenamide Fumarate Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Tenofovir Alafenamide Fumarate Production Capacity by Manufacturers
4.2 Global Tenofovir Alafenamide Fumarate Sales by Manufacturers
4.2.1 Global Tenofovir Alafenamide Fumarate Sales by Manufacturers (2017-2022)
4.2.2 Global Tenofovir Alafenamide Fumarate Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Tenofovir Alafenamide Fumarate in 2021
4.3 Global Tenofovir Alafenamide Fumarate Revenue by Manufacturers
4.3.1 Global Tenofovir Alafenamide Fumarate Revenue by Manufacturers (2017-2022)
4.3.2 Global Tenofovir Alafenamide Fumarate Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Tenofovir Alafenamide Fumarate Revenue in 2021
4.4 Global Tenofovir Alafenamide Fumarate Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Tenofovir Alafenamide Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Tenofovir Alafenamide Fumarate Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Tenofovir Alafenamide Fumarate Sales by Type
5.1.1 Global Tenofovir Alafenamide Fumarate Historical Sales by Type (2017-2022)
5.1.2 Global Tenofovir Alafenamide Fumarate Forecasted Sales by Type (2023-2028)
5.1.3 Global Tenofovir Alafenamide Fumarate Sales Market Share by Type (2017-2028)
5.2 Global Tenofovir Alafenamide Fumarate Revenue by Type
5.2.1 Global Tenofovir Alafenamide Fumarate Historical Revenue by Type (2017-2022)
5.2.2 Global Tenofovir Alafenamide Fumarate Forecasted Revenue by Type (2023-2028)
5.2.3 Global Tenofovir Alafenamide Fumarate Revenue Market Share by Type (2017-2028)
5.3 Global Tenofovir Alafenamide Fumarate Price by Type
5.3.1 Global Tenofovir Alafenamide Fumarate Price by Type (2017-2022)
5.3.2 Global Tenofovir Alafenamide Fumarate Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Tenofovir Alafenamide Fumarate Sales by Application
6.1.1 Global Tenofovir Alafenamide Fumarate Historical Sales by Application (2017-2022)
6.1.2 Global Tenofovir Alafenamide Fumarate Forecasted Sales by Application (2023-2028)
6.1.3 Global Tenofovir Alafenamide Fumarate Sales Market Share by Application (2017-2028)
6.2 Global Tenofovir Alafenamide Fumarate Revenue by Application
6.2.1 Global Tenofovir Alafenamide Fumarate Historical Revenue by Application (2017-2022)
6.2.2 Global Tenofovir Alafenamide Fumarate Forecasted Revenue by Application (2023-2028)
6.2.3 Global Tenofovir Alafenamide Fumarate Revenue Market Share by Application (2017-2028)
6.3 Global Tenofovir Alafenamide Fumarate Price by Application
6.3.1 Global Tenofovir Alafenamide Fumarate Price by Application (2017-2022)
6.3.2 Global Tenofovir Alafenamide Fumarate Price Forecast by Application (2023-2028)
7 North America
7.1 North America Tenofovir Alafenamide Fumarate Market Size by Type
7.1.1 North America Tenofovir Alafenamide Fumarate Sales by Type (2017-2028)
7.1.2 North America Tenofovir Alafenamide Fumarate Revenue by Type (2017-2028)
7.2 North America Tenofovir Alafenamide Fumarate Market Size by Application
7.2.1 North America Tenofovir Alafenamide Fumarate Sales by Application (2017-2028)
7.2.2 North America Tenofovir Alafenamide Fumarate Revenue by Application (2017-2028)
7.3 North America Tenofovir Alafenamide Fumarate Sales by Country
7.3.1 North America Tenofovir Alafenamide Fumarate Sales by Country (2017-2028)
7.3.2 North America Tenofovir Alafenamide Fumarate Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Tenofovir Alafenamide Fumarate Market Size by Type
8.1.1 Europe Tenofovir Alafenamide Fumarate Sales by Type (2017-2028)
8.1.2 Europe Tenofovir Alafenamide Fumarate Revenue by Type (2017-2028)
8.2 Europe Tenofovir Alafenamide Fumarate Market Size by Application
8.2.1 Europe Tenofovir Alafenamide Fumarate Sales by Application (2017-2028)
8.2.2 Europe Tenofovir Alafenamide Fumarate Revenue by Application (2017-2028)
8.3 Europe Tenofovir Alafenamide Fumarate Sales by Country
8.3.1 Europe Tenofovir Alafenamide Fumarate Sales by Country (2017-2028)
8.3.2 Europe Tenofovir Alafenamide Fumarate Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Tenofovir Alafenamide Fumarate Market Size by Type
9.1.1 Asia Pacific Tenofovir Alafenamide Fumarate Sales by Type (2017-2028)
9.1.2 Asia Pacific Tenofovir Alafenamide Fumarate Revenue by Type (2017-2028)
9.2 Asia Pacific Tenofovir Alafenamide Fumarate Market Size by Application
9.2.1 Asia Pacific Tenofovir Alafenamide Fumarate Sales by Application (2017-2028)
9.2.2 Asia Pacific Tenofovir Alafenamide Fumarate Revenue by Application (2017-2028)
9.3 Asia Pacific Tenofovir Alafenamide Fumarate Sales by Region
9.3.1 Asia Pacific Tenofovir Alafenamide Fumarate Sales by Region (2017-2028)
9.3.2 Asia Pacific Tenofovir Alafenamide Fumarate Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Tenofovir Alafenamide Fumarate Market Size by Type
10.1.1 Latin America Tenofovir Alafenamide Fumarate Sales by Type (2017-2028)
10.1.2 Latin America Tenofovir Alafenamide Fumarate Revenue by Type (2017-2028)
10.2 Latin America Tenofovir Alafenamide Fumarate Market Size by Application
10.2.1 Latin America Tenofovir Alafenamide Fumarate Sales by Application (2017-2028)
10.2.2 Latin America Tenofovir Alafenamide Fumarate Revenue by Application (2017-2028)
10.3 Latin America Tenofovir Alafenamide Fumarate Sales by Country
10.3.1 Latin America Tenofovir Alafenamide Fumarate Sales by Country (2017-2028)
10.3.2 Latin America Tenofovir Alafenamide Fumarate Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Tenofovir Alafenamide Fumarate Market Size by Type
11.1.1 Middle East and Africa Tenofovir Alafenamide Fumarate Sales by Type (2017-2028)
11.1.2 Middle East and Africa Tenofovir Alafenamide Fumarate Revenue by Type (2017-2028)
11.2 Middle East and Africa Tenofovir Alafenamide Fumarate Market Size by Application
11.2.1 Middle East and Africa Tenofovir Alafenamide Fumarate Sales by Application (2017-2028)
11.2.2 Middle East and Africa Tenofovir Alafenamide Fumarate Revenue by Application (2017-2028)
11.3 Middle East and Africa Tenofovir Alafenamide Fumarate Sales by Country
11.3.1 Middle East and Africa Tenofovir Alafenamide Fumarate Sales by Country (2017-2028)
11.3.2 Middle East and Africa Tenofovir Alafenamide Fumarate Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 AFINE CHEMICALS LIMITED
12.1.1 AFINE CHEMICALS LIMITED Corporation Information
12.1.2 AFINE CHEMICALS LIMITED Overview
12.1.3 AFINE CHEMICALS LIMITED Tenofovir Alafenamide Fumarate Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 AFINE CHEMICALS LIMITED Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 AFINE CHEMICALS LIMITED Recent Developments
12.2 BOC Sciences
12.2.1 BOC Sciences Corporation Information
12.2.2 BOC Sciences Overview
12.2.3 BOC Sciences Tenofovir Alafenamide Fumarate Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 BOC Sciences Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 BOC Sciences Recent Developments
12.3 ENBRIDGE PHARMTECH
12.3.1 ENBRIDGE PHARMTECH Corporation Information
12.3.2 ENBRIDGE PHARMTECH Overview
12.3.3 ENBRIDGE PHARMTECH Tenofovir Alafenamide Fumarate Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 ENBRIDGE PHARMTECH Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 ENBRIDGE PHARMTECH Recent Developments
12.4 SimSon Pharma Limited
12.4.1 SimSon Pharma Limited Corporation Information
12.4.2 SimSon Pharma Limited Overview
12.4.3 SimSon Pharma Limited Tenofovir Alafenamide Fumarate Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 SimSon Pharma Limited Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 SimSon Pharma Limited Recent Developments
12.5 Valorpharm
12.5.1 Valorpharm Corporation Information
12.5.2 Valorpharm Overview
12.5.3 Valorpharm Tenofovir Alafenamide Fumarate Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Valorpharm Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Valorpharm Recent Developments
12.6 Watson
12.6.1 Watson Corporation Information
12.6.2 Watson Overview
12.6.3 Watson Tenofovir Alafenamide Fumarate Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Watson Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Watson Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Tenofovir Alafenamide Fumarate Industry Chain Analysis
13.2 Tenofovir Alafenamide Fumarate Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Tenofovir Alafenamide Fumarate Production Mode & Process
13.4 Tenofovir Alafenamide Fumarate Sales and Marketing
13.4.1 Tenofovir Alafenamide Fumarate Sales Channels
13.4.2 Tenofovir Alafenamide Fumarate Distributors
13.5 Tenofovir Alafenamide Fumarate Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Tenofovir Alafenamide Fumarate Industry Trends
14.2 Tenofovir Alafenamide Fumarate Market Drivers
14.3 Tenofovir Alafenamide Fumarate Market Challenges
14.4 Tenofovir Alafenamide Fumarate Market Restraints
15 Key Finding in The Global Tenofovir Alafenamide Fumarate Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Tenofovir Alafenamide Fumarate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity 97%
Table 3. Major Manufacturers of Purity 98%
Table 4. Major Manufacturers of Purity 99%
Table 5. Global Tenofovir Alafenamide Fumarate Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Tenofovir Alafenamide Fumarate Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 7. Global Tenofovir Alafenamide Fumarate Production by Region (2017-2022) & (Tons)
Table 8. Global Tenofovir Alafenamide Fumarate Production Market Share by Region (2017-2022)
Table 9. Global Tenofovir Alafenamide Fumarate Production by Region (2023-2028) & (Tons)
Table 10. Global Tenofovir Alafenamide Fumarate Production Market Share by Region (2023-2028)
Table 11. Global Tenofovir Alafenamide Fumarate Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Tenofovir Alafenamide Fumarate Sales by Region (2017-2022) & (Tons)
Table 13. Global Tenofovir Alafenamide Fumarate Sales Market Share by Region (2017-2022)
Table 14. Global Tenofovir Alafenamide Fumarate Sales by Region (2023-2028) & (Tons)
Table 15. Global Tenofovir Alafenamide Fumarate Sales Market Share by Region (2023-2028)
Table 16. Global Tenofovir Alafenamide Fumarate Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Tenofovir Alafenamide Fumarate Revenue Market Share by Region (2017-2022)
Table 18. Global Tenofovir Alafenamide Fumarate Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Tenofovir Alafenamide Fumarate Revenue Market Share by Region (2023-2028)
Table 20. Global Tenofovir Alafenamide Fumarate Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 21. Global Tenofovir Alafenamide Fumarate Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Tenofovir Alafenamide Fumarate Sales by Manufacturers (2017-2022) & (Tons)
Table 23. Global Tenofovir Alafenamide Fumarate Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Tenofovir Alafenamide Fumarate Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Tenofovir Alafenamide Fumarate Revenue Share by Manufacturers (2017-2022)
Table 26. Tenofovir Alafenamide Fumarate Price by Manufacturers 2017-2022 (US$/Ton)
Table 27. Global Tenofovir Alafenamide Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Tenofovir Alafenamide Fumarate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenofovir Alafenamide Fumarate as of 2021)
Table 29. Tenofovir Alafenamide Fumarate Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Tenofovir Alafenamide Fumarate Product Offered
Table 31. Date of Manufacturers Enter into Tenofovir Alafenamide Fumarate Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Tenofovir Alafenamide Fumarate Sales by Type (2017-2022) & (Tons)
Table 34. Global Tenofovir Alafenamide Fumarate Sales by Type (2023-2028) & (Tons)
Table 35. Global Tenofovir Alafenamide Fumarate Sales Share by Type (2017-2022)
Table 36. Global Tenofovir Alafenamide Fumarate Sales Share by Type (2023-2028)
Table 37. Global Tenofovir Alafenamide Fumarate Revenue by Type (2017-2022) & (US$ Million)
Table 38. Global Tenofovir Alafenamide Fumarate Revenue by Type (2023-2028) & (US$ Million)
Table 39. Global Tenofovir Alafenamide Fumarate Revenue Share by Type (2017-2022)
Table 40. Global Tenofovir Alafenamide Fumarate Revenue Share by Type (2023-2028)
Table 41. Tenofovir Alafenamide Fumarate Price by Type (2017-2022) & (US$/Ton)
Table 42. Global Tenofovir Alafenamide Fumarate Price Forecast by Type (2023-2028) & (US$/Ton)
Table 43. Global Tenofovir Alafenamide Fumarate Sales by Application (2017-2022) & (Tons)
Table 44. Global Tenofovir Alafenamide Fumarate Sales by Application (2023-2028) & (Tons)
Table 45. Global Tenofovir Alafenamide Fumarate Sales Share by Application (2017-2022)
Table 46. Global Tenofovir Alafenamide Fumarate Sales Share by Application (2023-2028)
Table 47. Global Tenofovir Alafenamide Fumarate Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Tenofovir Alafenamide Fumarate Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Tenofovir Alafenamide Fumarate Revenue Share by Application (2017-2022)
Table 50. Global Tenofovir Alafenamide Fumarate Revenue Share by Application (2023-2028)
Table 51. Tenofovir Alafenamide Fumarate Price by Application (2017-2022) & (US$/Ton)
Table 52. Global Tenofovir Alafenamide Fumarate Price Forecast by Application (2023-2028) & (US$/Ton)
Table 53. North America Tenofovir Alafenamide Fumarate Sales by Type (2017-2022) & (Tons)
Table 54. North America Tenofovir Alafenamide Fumarate Sales by Type (2023-2028) & (Tons)
Table 55. North America Tenofovir Alafenamide Fumarate Revenue by Type (2017-2022) & (US$ Million)
Table 56. North America Tenofovir Alafenamide Fumarate Revenue by Type (2023-2028) & (US$ Million)
Table 57. North America Tenofovir Alafenamide Fumarate Sales by Application (2017-2022) & (Tons)
Table 58. North America Tenofovir Alafenamide Fumarate Sales by Application (2023-2028) & (Tons)
Table 59. North America Tenofovir Alafenamide Fumarate Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Tenofovir Alafenamide Fumarate Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Tenofovir Alafenamide Fumarate Sales by Country (2017-2022) & (Tons)
Table 62. North America Tenofovir Alafenamide Fumarate Sales by Country (2023-2028) & (Tons)
Table 63. North America Tenofovir Alafenamide Fumarate Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Tenofovir Alafenamide Fumarate Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Tenofovir Alafenamide Fumarate Sales by Type (2017-2022) & (Tons)
Table 66. Europe Tenofovir Alafenamide Fumarate Sales by Type (2023-2028) & (Tons)
Table 67. Europe Tenofovir Alafenamide Fumarate Revenue by Type (2017-2022) & (US$ Million)
Table 68. Europe Tenofovir Alafenamide Fumarate Revenue by Type (2023-2028) & (US$ Million)
Table 69. Europe Tenofovir Alafenamide Fumarate Sales by Application (2017-2022) & (Tons)
Table 70. Europe Tenofovir Alafenamide Fumarate Sales by Application (2023-2028) & (Tons)
Table 71. Europe Tenofovir Alafenamide Fumarate Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Tenofovir Alafenamide Fumarate Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Tenofovir Alafenamide Fumarate Sales by Country (2017-2022) & (Tons)
Table 74. Europe Tenofovir Alafenamide Fumarate Sales by Country (2023-2028) & (Tons)
Table 75. Europe Tenofovir Alafenamide Fumarate Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Tenofovir Alafenamide Fumarate Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Tenofovir Alafenamide Fumarate Sales by Type (2017-2022) & (Tons)
Table 78. Asia Pacific Tenofovir Alafenamide Fumarate Sales by Type (2023-2028) & (Tons)
Table 79. Asia Pacific Tenofovir Alafenamide Fumarate Revenue by Type (2017-2022) & (US$ Million)
Table 80. Asia Pacific Tenofovir Alafenamide Fumarate Revenue by Type (2023-2028) & (US$ Million)
Table 81. Asia Pacific Tenofovir Alafenamide Fumarate Sales by Application (2017-2022) & (Tons)
Table 82. Asia Pacific Tenofovir Alafenamide Fumarate Sales by Application (2023-2028) & (Tons)
Table 83. Asia Pacific Tenofovir Alafenamide Fumarate Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Tenofovir Alafenamide Fumarate Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Tenofovir Alafenamide Fumarate Sales by Region (2017-2022) & (Tons)
Table 86. Asia Pacific Tenofovir Alafenamide Fumarate Sales by Region (2023-2028) & (Tons)
Table 87. Asia Pacific Tenofovir Alafenamide Fumarate Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Tenofovir Alafenamide Fumarate Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Tenofovir Alafenamide Fumarate Sales by Type (2017-2022) & (Tons)
Table 90. Latin America Tenofovir Alafenamide Fumarate Sales by Type (2023-2028) & (Tons)
Table 91. Latin America Tenofovir Alafenamide Fumarate Revenue by Type (2017-2022) & (US$ Million)
Table 92. Latin America Tenofovir Alafenamide Fumarate Revenue by Type (2023-2028) & (US$ Million)
Table 93. Latin America Tenofovir Alafenamide Fumarate Sales by Application (2017-2022) & (Tons)
Table 94. Latin America Tenofovir Alafenamide Fumarate Sales by Application (2023-2028) & (Tons)
Table 95. Latin America Tenofovir Alafenamide Fumarate Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Tenofovir Alafenamide Fumarate Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Tenofovir Alafenamide Fumarate Sales by Country (2017-2022) & (Tons)
Table 98. Latin America Tenofovir Alafenamide Fumarate Sales by Country (2023-2028) & (Tons)
Table 99. Latin America Tenofovir Alafenamide Fumarate Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Tenofovir Alafenamide Fumarate Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Tenofovir Alafenamide Fumarate Sales by Type (2017-2022) & (Tons)
Table 102. Middle East and Africa Tenofovir Alafenamide Fumarate Sales by Type (2023-2028) & (Tons)
Table 103. Middle East and Africa Tenofovir Alafenamide Fumarate Revenue by Type (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Tenofovir Alafenamide Fumarate Revenue by Type (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Tenofovir Alafenamide Fumarate Sales by Application (2017-2022) & (Tons)
Table 106. Middle East and Africa Tenofovir Alafenamide Fumarate Sales by Application (2023-2028) & (Tons)
Table 107. Middle East and Africa Tenofovir Alafenamide Fumarate Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Tenofovir Alafenamide Fumarate Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Tenofovir Alafenamide Fumarate Sales by Country (2017-2022) & (Tons)
Table 110. Middle East and Africa Tenofovir Alafenamide Fumarate Sales by Country (2023-2028) & (Tons)
Table 111. Middle East and Africa Tenofovir Alafenamide Fumarate Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Tenofovir Alafenamide Fumarate Revenue by Country (2023-2028) & (US$ Million)
Table 113. AFINE CHEMICALS LIMITED Corporation Information
Table 114. AFINE CHEMICALS LIMITED Description and Major Businesses
Table 115. AFINE CHEMICALS LIMITED Tenofovir Alafenamide Fumarate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 116. AFINE CHEMICALS LIMITED Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. AFINE CHEMICALS LIMITED Recent Development
Table 118. BOC Sciences Corporation Information
Table 119. BOC Sciences Description and Major Businesses
Table 120. BOC Sciences Tenofovir Alafenamide Fumarate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 121. BOC Sciences Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. BOC Sciences Recent Development
Table 123. ENBRIDGE PHARMTECH Corporation Information
Table 124. ENBRIDGE PHARMTECH Description and Major Businesses
Table 125. ENBRIDGE PHARMTECH Tenofovir Alafenamide Fumarate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 126. ENBRIDGE PHARMTECH Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. ENBRIDGE PHARMTECH Recent Development
Table 128. SimSon Pharma Limited Corporation Information
Table 129. SimSon Pharma Limited Description and Major Businesses
Table 130. SimSon Pharma Limited Tenofovir Alafenamide Fumarate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 131. SimSon Pharma Limited Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. SimSon Pharma Limited Recent Development
Table 133. Valorpharm Corporation Information
Table 134. Valorpharm Description and Major Businesses
Table 135. Valorpharm Tenofovir Alafenamide Fumarate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 136. Valorpharm Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Valorpharm Recent Development
Table 138. Watson Corporation Information
Table 139. Watson Description and Major Businesses
Table 140. Watson Tenofovir Alafenamide Fumarate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 141. Watson Tenofovir Alafenamide Fumarate Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Watson Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Tenofovir Alafenamide Fumarate Distributors List
Table 146. Tenofovir Alafenamide Fumarate Customers List
Table 147. Tenofovir Alafenamide Fumarate Market Trends
Table 148. Tenofovir Alafenamide Fumarate Market Drivers
Table 149. Tenofovir Alafenamide Fumarate Market Challenges
Table 150. Tenofovir Alafenamide Fumarate Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Tenofovir Alafenamide Fumarate Product Picture
Figure 2. Global Tenofovir Alafenamide Fumarate Market Share by Type in 2021 & 2028
Figure 3. Purity 97% Product Picture
Figure 4. Purity 98% Product Picture
Figure 5. Purity 99% Product Picture
Figure 6. Global Tenofovir Alafenamide Fumarate Market Share by Application in 2021 & 2028
Figure 7. Medicine
Figure 8. Chemical Industry
Figure 9. Other
Figure 10. Tenofovir Alafenamide Fumarate Report Years Considered
Figure 11. Global Tenofovir Alafenamide Fumarate Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 12. Global Tenofovir Alafenamide Fumarate Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Tenofovir Alafenamide Fumarate Production Market Share by Region (2017-2022)
Figure 14. Global Tenofovir Alafenamide Fumarate Production Market Share by Region (2023-2028)
Figure 15. Tenofovir Alafenamide Fumarate Production Growth Rate in North America (2017-2028) & (Tons)
Figure 16. Tenofovir Alafenamide Fumarate Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 17. Tenofovir Alafenamide Fumarate Production Growth Rate in China (2017-2028) & (Tons)
Figure 18. Tenofovir Alafenamide Fumarate Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 19. Global Tenofovir Alafenamide Fumarate Sales 2017-2028 (Tons)
Figure 20. Global Tenofovir Alafenamide Fumarate Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Tenofovir Alafenamide Fumarate Revenue 2017-2028 (US$ Million)
Figure 22. Global Tenofovir Alafenamide Fumarate Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Tenofovir Alafenamide Fumarate Sales Market Share by Region (2017-2022)
Figure 24. Global Tenofovir Alafenamide Fumarate Sales Market Share by Region (2023-2028)
Figure 25. North America Tenofovir Alafenamide Fumarate Sales YoY (2017-2028) & (Tons)
Figure 26. North America Tenofovir Alafenamide Fumarate Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Tenofovir Alafenamide Fumarate Sales YoY (2017-2028) & (Tons)
Figure 28. Europe Tenofovir Alafenamide Fumarate Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Tenofovir Alafenamide Fumarate Sales YoY (2017-2028) & (Tons)
Figure 30. Asia-Pacific Tenofovir Alafenamide Fumarate Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Tenofovir Alafenamide Fumarate Sales YoY (2017-2028) & (Tons)
Figure 32. Latin America Tenofovir Alafenamide Fumarate Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Tenofovir Alafenamide Fumarate Sales YoY (2017-2028) & (Tons)
Figure 34. Middle East & Africa Tenofovir Alafenamide Fumarate Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Tenofovir Alafenamide Fumarate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Tenofovir Alafenamide Fumarate in the World: Market Share by Tenofovir Alafenamide Fumarate Revenue in 2021
Figure 37. Tenofovir Alafenamide Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Tenofovir Alafenamide Fumarate Sales Market Share by Type (2017-2028)
Figure 39. Global Tenofovir Alafenamide Fumarate Revenue Market Share by Type (2017-2028)
Figure 40. Global Tenofovir Alafenamide Fumarate Sales Market Share by Application (2017-2028)
Figure 41. Global Tenofovir Alafenamide Fumarate Revenue Market Share by Application (2017-2028)
Figure 42. North America Tenofovir Alafenamide Fumarate Sales Market Share by Type (2017-2028)
Figure 43. North America Tenofovir Alafenamide Fumarate Revenue Market Share by Type (2017-2028)
Figure 44. North America Tenofovir Alafenamide Fumarate Sales Market Share by Application (2017-2028)
Figure 45. North America Tenofovir Alafenamide Fumarate Revenue Market Share by Application (2017-2028)
Figure 46. North America Tenofovir Alafenamide Fumarate Sales Share by Country (2017-2028)
Figure 47. North America Tenofovir Alafenamide Fumarate Revenue Share by Country (2017-2028)
Figure 48. United States Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Tenofovir Alafenamide Fumarate Sales Market Share by Type (2017-2028)
Figure 51. Europe Tenofovir Alafenamide Fumarate Revenue Market Share by Type (2017-2028)
Figure 52. Europe Tenofovir Alafenamide Fumarate Sales Market Share by Application (2017-2028)
Figure 53. Europe Tenofovir Alafenamide Fumarate Revenue Market Share by Application (2017-2028)
Figure 54. Europe Tenofovir Alafenamide Fumarate Sales Share by Country (2017-2028)
Figure 55. Europe Tenofovir Alafenamide Fumarate Revenue Share by Country (2017-2028)
Figure 56. Germany Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 57. France Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Tenofovir Alafenamide Fumarate Sales Market Share by Type (2017-2028)
Figure 62. Asia Pacific Tenofovir Alafenamide Fumarate Revenue Market Share by Type (2017-2028)
Figure 63. Asia Pacific Tenofovir Alafenamide Fumarate Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Tenofovir Alafenamide Fumarate Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Tenofovir Alafenamide Fumarate Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Tenofovir Alafenamide Fumarate Revenue Share by Region (2017-2028)
Figure 67. China Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 70. India Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 72. China Taiwan Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America Tenofovir Alafenamide Fumarate Sales Market Share by Type (2017-2028)
Figure 77. Latin America Tenofovir Alafenamide Fumarate Revenue Market Share by Type (2017-2028)
Figure 78. Latin America Tenofovir Alafenamide Fumarate Sales Market Share by Application (2017-2028)
Figure 79. Latin America Tenofovir Alafenamide Fumarate Revenue Market Share by Application (2017-2028)
Figure 80. Latin America Tenofovir Alafenamide Fumarate Sales Share by Country (2017-2028)
Figure 81. Latin America Tenofovir Alafenamide Fumarate Revenue Share by Country (2017-2028)
Figure 82. Mexico Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 85. Colombia Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 86. Middle East and Africa Tenofovir Alafenamide Fumarate Sales Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Tenofovir Alafenamide Fumarate Revenue Market Share by Type (2017-2028)
Figure 88. Middle East and Africa Tenofovir Alafenamide Fumarate Sales Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Tenofovir Alafenamide Fumarate Revenue Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Tenofovir Alafenamide Fumarate Sales Share by Country (2017-2028)
Figure 91. Middle East and Africa Tenofovir Alafenamide Fumarate Revenue Share by Country (2017-2028)
Figure 92. Turkey Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 93. Saudi Arabia Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 94. UAE Tenofovir Alafenamide Fumarate Revenue (2017-2028) & (US$ Million)
Figure 95. Tenofovir Alafenamide Fumarate Value Chain
Figure 96. Tenofovir Alafenamide Fumarate Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed

Global 2-Propylheptyl Acrylate (2-PHA) Market Insights, Forecast to 2028
QY2203B01339 2022年3月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界のアクリル酸2-プロピルヘプチル(2-PHA)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、20...

ロジックアナライザーのグローバル市場インサイト・予測（～2028年）

Global Logic Analyzer Market Insights and Forecast to 2028
QY2203B07230 2022年3月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界のロジックアナライザーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にロジックアナライ...

ボンディングワニスのグローバル市場インサイト・予測（～2028年）

Global Bonding Varnish Market Insights and Forecast to 2028
QY2203B06330 2022年3月 70Pages
新型コロナウイルス感染症のパンデミックにより、世界のボンディングワニスの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にボンディングワニス...

1,3-プロパンジオール (PDO)のグローバル市場インサイト・予測（～2028年）

Global 1,3-Propanediol(PDO) Market Insights and Forecast to 2028
QY2203B00031 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界の1,3-プロパンジオール (PDO)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...

パンクレリパーゼのグローバル市場インサイト・予測（～2028年）

Global Pancrelipase Market Insights and Forecast to 2028
QY2203B05040 2022年3月 72Pages
新型コロナウイルス感染症のパンデミックにより、世界のパンクレリパーゼの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパンクレリパーゼの世...

Eインクスクリーンのグローバル市場インサイト・予測（～2028年）

Global E-ink Screens Market Insights and Forecast to 2028
QY2203B00584 2022年3月 72Pages
新型コロナウイルス感染症のパンデミックにより、世界のEインクスクリーンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にEインクスクリーン...

パルスチェイス解析のグローバル市場インサイト・予測（～2028年）

Global Pulse-chase Analysis Market Insights, Forecast to 2028
QY2203B04973 2022年3月 79Pages
新型コロナウイルス感染症のパンデミックにより、世界のパルスチェイス解析の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパルスチェイス解析...

フルシトシン錠のグローバル市場インサイト・予測（～2028年）

Global Flucytosine Tablets Market Insights and Forecast to 2028
QY2203B05663 2022年3月 76Pages
新型コロナウイルス感染症のパンデミックにより、世界のフルシトシン錠の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフルシトシン錠の世界市...

ジメチルアミノメチルシクロヘキサノンのグローバル市場インサイト・予測（～2028年）

Pages
...

スピンオンドーパントのグローバル市場インサイト・予測（～2028年）

Global Spin-on Dopant Market Insights, Forecast to 2028
QY2203B03540 2022年3月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界のスピンオンドーパントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスピンオンドーパ...

高純度モリブデンのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global High Purity Molybdenum Market Due to the COVID-19 pandemic, the global High Purity Molybdenum market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully con…
メタクリル酸シクロヘキシル(CHMA)のグローバル市場インサイト・予測（～2028年） Cyclohexyl methacrylate is a chemical used for reactive coatings, adhesives, resins, and sealants.Cyclohexyl Methacrylate (CHMA) is a monofunctional monomer with a characteristic high reactivity of methacrylates and a cyclic hydrophobic moiety. Market Analysis and Insights: Global Cyclohexyl Methacr…
高純度無水塩化アルミニウムのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global High Purity Anhydrous Aluminum Chloride Market Due to the COVID-19 pandemic, the global High Purity Anhydrous Aluminum Chloride market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % d…
パラジウムインゴットのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Palladium Ingots Market Due to the COVID-19 pandemic, the global Palladium Ingots market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully con…
高純度塩酸のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global High Purity Hydrochloric Acid Market Due to the COVID-19 pandemic, the global High Purity Hydrochloric Acid market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review per…